Biomarker analysis in drug discovery and development has significantly improved the development of new therapeutics. Biomarker testing services help to evaluate effects of novel therapeutic compounds on biological pathways, including gene transcription, DNA methylation and others. Testing biomarkers at either the DNA or protein level has been used by physicians for decades to study human diseases. Physicians readily rely on biomarker services to diagnose and manage clinical conditions such as cardiovascular diseases, cancer, immune responses, genetic disorders and more. The application of biomarker assay in research has recently exploded out of a desire to gain crucial information about biological reactions upon exposure to novel therapeutic compounds.
Biomarker testing services provide a powerful approach to measuring biological process indicators in normal and pathological conditions or in response to pharmacological intervention. Biomarker analysis in blood or other bodily fluids at either the DNA or protein level has been used by physicians for decades to study human diseases. Physicians readily rely on biomarker services to diagnose and manage clinical conditions such as cardiovascular diseases, cancer and immune responses. Biomarker analysis is a powerful approach to measuring biological process indicators in normal and pathological conditions or in response to pharmacological intervention. Biomarker testing services provide valuable information about the safety and efficacy of a drug candidate in its early stages of development. These services help pharmaceutical companies identify new therapeutic targets, understand underlying mechanisms of disease, and develop safe drugs for patients who are suffering from chronic diseases associated with aging.
NorthEast BioLab is a bioanalytical services lab with 15+ years experience in providing small and large molecule bioanalysis for clinical, preclinical, and drug discovery studies. Our team has an excellent track record of advancing Pharmacokinetics (PK), Bioavailability and Bioequivalence (BA/BE), Toxicokinetics (TK), Immunogenicity (ADA), Biomarker Testing, and Custom Assays. We offer Method Development and Validation using LC-MS/MS, ELISA, MSD ECL, Luminex Multiplex, Western Blot, and qPCR, among other technologies.
Bioanalytical lab providing small and large molecule bioanalysis for clinical, preclinical and drug discovery studies with excellent track record. We offer Method Development and Validation using LC-MS/MS, ELISA, MSD ECL, Luminex Multiplex, Western Blot and qPCR among other technologies. GLP/GCLP compliant status ensures that our results are accurate and reliable; FDA audited facility to ensure compliance with the highest standards; DEA & CT State Schedule II-IV approved facility in case you need to meet those regulations.
NorthEast BioLab is a bioanalytical lab with 15+ years experience in providing small and large molecule bioanalysis for clinical, preclinical, and drug discovery studies. Our team has an excellent track record of advancing Pharmacokinetics (PK), Bioavailability and Bioequivalence (BA/BE), Toxicokinetics (TK), Immunogenicity (ADA), Biomarker Testing, and Custom Assays. At Northeast BioLab, we are committed to delivering exceptional customer service and quality results. Our expert team creates innovative analytical services that meet the needs of pharmaceutical, biotech, and diagnostic companies from around the globe. We use advanced instrumentation and techniques such as LC-MS/MS, ELISA, MSD ECL, Luminex Multiplex, Western Blot, and qPCR to offer superior processes in microbiology testing and development of custom applications for research studies.